UK markets open in 7 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5800+0.0700 (+2.79%)
At close: 04:00PM EDT
2.5500 -0.03 (-1.16%)
After hours: 05:15PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
170,276
170,276
185,308
154,344
98,382
Cost of revenue
75,553
75,553
57,909
49,301
22,530
Gross profit
94,723
94,723
127,399
105,043
75,852
Operating expenses
Research development
122,117
122,117
141,756
142,343
116,072
Selling general and administrative
172,513
172,513
184,130
169,967
110,894
Total operating expenses
296,329
296,329
327,585
314,009
228,669
Operating income or loss
-201,606
-201,606
-200,186
-208,966
-152,817
Interest expense
13,800
13,800
4,238
0
-
Total other income/expenses net
-25,429
-25,429
-
-
-
Income before tax
-225,304
-225,304
-200,368
-207,298
-146,227
Income from continuing operations
-225,304
-225,304
-200,368
-207,298
-146,227
Net income
-225,250
-225,250
-200,191
-207,279
-146,227
Net income available to common shareholders
-225,250
-225,250
-200,191
-207,279
-146,227
Basic EPS
-1.40
-1.56
-1.40
-1.48
-1.11
Diluted EPS
-1.40
-1.56
-1.40
-1.48
-1.11
Basic average shares
142,516
144,383
142,516
140,355
131,216
Diluted average shares
142,516
144,383
142,516
140,355
131,216